Evidence map›Paper›PMID 33230584›Full record

ArticleJournal of cancer research and clinical oncology2021

Correction to: Stereotactic body radiotherapy for elderly patients (≥ 75 years) with early‑stage non‑small cell lung cancer.

Zekai Shu, Baiqiang Dong, Lei Shi, Wei Shen, Qingqing Hang, Jin Wang, Yuanyuan Chen

Open access · bronzeAbstract readPublished Erratum
In one paragraph

Article in Journal of cancer research and clinical oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Zekai Shu *The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
Baiqiang Dong *School of Radiation Medicine and Protection, Medical College of Soochow University, Suzhou, 215123, China.
Lei ShiHangzhou YITU Healthcare Technology Co., Ltd, Hangzhou, 310012, China.
Wei ShenHangzhou YITU Healthcare Technology Co., Ltd, Hangzhou, 310012, China.
Qingqing HangThe Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
Jin WangInstitute of Cancer Research and Basic Medical Sciences, Chinese Academy of Sciences, Hangzhou, 310011, China. wangjin@zjcc.org.cn.
Yuanyuan ChenInstitute of Cancer Research and Basic Medical Sciences, Chinese Academy of Sciences, Hangzhou, 310011, China. chenyy@zjcc.org.cn.ORCID https://orcid.org/0000-0002-9655-7828
Zhejiang Chinese Medical University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNChinese Academy of Sciences · CNSoochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33230584
PMCPMC11801874
OpenAlexW3106893982

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.